ARTICLE | Clinical News
Mitizax: Phase III data
July 27, 2015 7:00 AM UTC
Top-line data from a double-blind, North American Phase III trial in about 1,500 patients ages >=12 with house dust mite allergic rhinitis or rhinoconjunctivitis showed that once-daily Mitizax met the...